Apotea (APOTEA) - Total Assets
Based on the latest financial reports, Apotea (APOTEA) holds total assets worth Skr2.22 Billion SEK (≈ $238.99 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Apotea for net asset value and shareholders' equity analysis.
Apotea - Total Assets Trend (2022–2025)
This chart illustrates how Apotea's total assets have evolved over time, based on quarterly financial data.
Apotea - Asset Composition Analysis
Current Asset Composition (December 2025)
Apotea's total assets of Skr2.22 Billion consist of 56.5% current assets and 43.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 1.6% |
| Accounts Receivable | Skr355.40 Million | 17.9% |
| Inventory | Skr651.90 Million | 32.9% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr14.10 Million | 0.7% |
| Goodwill | Skr30.50 Million | 1.5% |
Asset Composition Trend (2022–2025)
This chart illustrates how Apotea's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Apotea.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Apotea's current assets represent 56.5% of total assets in 2025, a decrease from 57.6% in 2022.
- Cash Position: Cash and equivalents constituted 1.6% of total assets in 2025, up from 1.5% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 4.0% in 2022.
- Asset Diversification: The largest asset category is inventory at 32.9% of total assets.
Apotea Competitors by Total Assets
Key competitors of Apotea based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.27 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$346.42 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.83 Billion |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥19.91 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.55 Billion |
Apotea - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.35 | 1.09 | 1.19 |
| Quick Ratio | 0.56 | 0.47 | 0.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr361.50 Million | Skr91.20 Million | Skr147.30 Million |
Apotea - Advanced Valuation Insights
This section examines the relationship between Apotea's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.38 |
| Latest Market Cap to Assets Ratio | 0.44 |
| Asset Growth Rate (YoY) | 21.7% |
| Total Assets | Skr1.98 Billion |
| Market Capitalization | $862.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Apotea's assets below their book value (0.44x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Apotea's assets grew by 21.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Apotea (2022–2025)
The table below shows the annual total assets of Apotea from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.98 Billion ≈ $213.13 Million |
+21.67% |
| 2024-12-31 | Skr1.63 Billion ≈ $175.17 Million |
+21.81% |
| 2023-12-31 | Skr1.34 Billion ≈ $143.81 Million |
+6.69% |
| 2022-12-31 | Skr1.25 Billion ≈ $134.79 Million |
-- |
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and dr… Read more